|
|
Article: Eden Biodesign Chosen by Omnio Healer AB for cGMP Production of Clinical Trial Product.
- Article from:
- Health & Beauty Close-Up
- Article date:
- August 11, 2009
CopyrightCOPYRIGHT 2009 Close-Up Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Eden Biodesign and Omnio Healer AB, a company that develops novel therapies for wound healing and anti-infection, announced that they have entered into a partnership agreement.
Based on a novel therapeutic concept for wound healing and anti-infection, Omnio Healer is developing drug candidates with potent pro-inflammatory functions, and under this new agreement, Eden Biodesign will provide process development and cGMP production services relating to Omnio Healer's lead recombinant protein candidate, the group noted in a release. Indeed, the agreement with Eden Biodesign relates to the expression of proteins through mammalian cell culture for use against several ...